Argentina approved the vaccination of children aged 3 to 11 with Sinopharm Xinguan vaccine

Original title: Argentina approved the vaccination of children aged 3 to 11 with Sinopharm Xinguan vaccine
Argentina approved the vaccination of children aged 3 to 11 with Sinopharm Xinguan vaccine
On October 1 local time, Argentine Minister of health bisoti announced that Argentina's national food, drug and medical technology administration has officially approved the vaccination of Chinese national drug Xinguan vaccine for domestic children aged 3 to 11.
Bisoti pointed out that the national medicine vaccine is one of the safest new vaccines at present. Therefore, vaccinating Argentine children with national medicine vaccine can not only protect their own safety, but also effectively curb the spread of the epidemic.
In addition, from October 1, Argentina abolished the mandatory epidemic prevention regulations for wearing masks outdoors, and further relaxed the number of people allowed to gather in indoor public places and public activities. This includes that the number of live spectators of football matches can be increased to 50% of the capacity of the auditorium, but at the same time, adult spectators need to have proof of at least one dose of new crown vaccine.
Novel coronavirus pneumonia was confirmed in 1564 cases in October 1st, and 5258466 cases were diagnosed in Argentina, according to the daily epidemic bulletin published by the Ministry of health. There were 46 new deaths in a single day, with a total of 115225 deaths; 5119953 cases were cured; There are 23288 confirmed cases. So far, Argentina has received more than 52.08 million doses of new crown vaccine, and about 23.38 million people have completed the whole process of vaccination.
Source: CCTV news client